APA-referens

Casati, S., Passerini, P., Campise, M. R., Graziani, G., Cesana, B., Perisic, M., & Ponticelli, C. (1987). Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.

Chicago-stil citat

Casati, S., P. Passerini, M R. Campise, G. Graziani, B. Cesana, M. Perisic, och C. Ponticelli. Benefits and Risks of Protracted Treatment With Human Recombinant Erythropoietin in Patients Having Haemodialysis. 1987.

MLA-referens

Casati, S., et al. Benefits and Risks of Protracted Treatment With Human Recombinant Erythropoietin in Patients Having Haemodialysis. 1987.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.